Recombinant factor VIII 1500 IU for hemophilia A treatment.
The State Enterprise 'Medical Procurement of Ukraine' is procuring recombinant human coagulation factor VIII (1500 IU) for the treatment of hemophilia A. The tender covers pharmaceutical products classified under CPV 33621000-9. Bidders must supply the specified medication in accordance with Ukrainian pharmaceutical regulations. The contract value is not disclosed, but the procurement is above the threshold for public tenders. Delivery is expected across Ukraine.